Skip to Content
Tim Coleman

Tim Coleman
Senior Vice President and Chief Technology Officer, Medicines Development, Eli Lilly and Company

Tim currently serves as the Senior Vice President and Chief Technology Officer, Medicines Development at Eli Lilly and Company, delivering IT strategies and solutions for research & development business areas. In this position, Tim directs a global portfolio of digital change initiatives in partnership with Lilly's senior business and scientific executives. During his 23-year tenure at Lilly, Tim has led national award-winning projects and initiatives for digital innovation and leadership, including the 2020 CIO 100 Award, 2020 FutureEdge Award, and the Bio-IT World Best Practices Award in Clinical Research.

Before serving in his current role, Tim drove the delivery of IT, sales & marketing, and research and development services. Tim’s career path with Lilly includes titles as the Director of Global Marketing & IT Sales, where he oversaw e-business project portfolios and liaised with senior executives to ensure fulfillment of business objectives. He also served as the Senior Director for Global Medical IT, where Tim managed comprehensive clinical research information systems and oversaw their optimization for medical utilization.

Tim is passionate about serving his community in various capacities outside of work. He serves as Executive Champion for BDPA Indianapolis and is on the board of directors for the TechPoint Youth Foundation and the national BDPA Education & Technology Foundation. Tim is also involved at his alma mater as a board member with the Krenicki Center for Business Analytics and Machine Learning at the Daniels School of Business.

Tim earned his Bachelor of Science in Industrial Management and Computer Science from Purdue University, where he was involved as a student with Iron Key, Society of Minority Managers, Omicron Delta Kappa, and the School of Management Council. He then earned his MBA in Marketing from Northwestern University’s Kellogg School of Management.